+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Endocrinology Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • PDF Icon

    Report

  • 111 Pages
  • July 2024
  • Region: Global
  • GlobalData
  • ID: 5996038
The Medical Devices sector report, “Endocrinology Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Endocrinology Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Endocrinology Tests are the reagents used for quantification and detection of endocrine hormones secreted in the human body.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Endocrinology Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Endocrinology Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to :

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Endocrinology Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Endocrinology Tests Overview
3 Products under Development
3.1 Endocrinology Tests - Pipeline Products by Stage of Development
3.2 Endocrinology Tests - Pipeline Products by Segment
3.3 Endocrinology Tests - Pipeline Products by Territory
3.4 Endocrinology Tests - Pipeline Products by Regulatory Path
3.5 Endocrinology Tests - Pipeline Products by Estimated Approval Date
4 Endocrinology Tests - Pipeline Products under Development by Companies
4.1 Endocrinology Tests Companies - Pipeline Products by Stage of Development
4.2 Endocrinology Tests - Pipeline Products by Stage of Development
5 Endocrinology Tests Companies and Product Overview6 Endocrinology Tests- Recent Developments
7 Appendix
7.1 Methodology
7.2 About the Analyst
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
  • Endocrinology Tests - Pipeline Products by Stage of Development
  • Endocrinology Tests - Pipeline Products by Segment
  • Endocrinology Tests - Pipeline Products by Territory
  • Endocrinology Tests - Pipeline Products by Regulatory Path
  • Endocrinology Tests - Pipeline Products by Estimated Approval Date
  • Endocrinology Tests Companies - Pipeline Products by Stage of Development
  • Endocrinology Tests - Pipeline Products by Stage of Development
  • Glossary
List of Figures
  • Endocrinology Tests - Pipeline Products by Stage of Development
  • Endocrinology Tests - Pipeline Products by Segment
  • Endocrinology Tests - Pipeline Products by Territory
  • Endocrinology Tests - Pipeline Products by Regulatory Path
  • Endocrinology Tests - Pipeline Products by Estimated Approval Date

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Aeterna Zentaris Inc
  • Albert Einstein College of Medicine
  • AMS Diagnostics LLC
  • Axis-Shield Diagnostics Ltd
  • Carolina Liquid Chemistries Corp
  • Ceres Nanosciences Inc
  • Columbia University
  • Denka Seiken Co Ltd
  • DIANA Biotechnologies SRO
  • DiaSorin SpA
  • EDP Biotech Corporation
  • G Medical Health and Wellness
  • Guangzhou Wondfo Biotech Co Ltd
  • Hansjorg Wyss Institute for Biologically Inspired Engineering
  • Intelligent Bio Solutions Inc
  • Laboratoire HRA Pharma SAS
  • Manchester University NHS Foundation Trust
  • MyHealthTest Pty Ltd
  • Pearsanta Inc
  • Philmedi Co Ltd
  • Revvity Inc
  • Roche Diagnostics Corp
  • Roche Diagnostics International Ltd
  • Sendera Discovery
  • Shenzhen Mindray Bio-Medical Electronics Co Ltd
  • Siemens Healthcare Diagnostics Inc
  • Solvd Health
  • Thermo Fisher Scientific Inc
  • Tosoh Bioscience Inc
  • University of California San Francisco